tetano
Editor, Senior Moderator
J Biomed Res. 2015 Apr;29(2):150-9. doi: 10.7555/JBR.29.20130024. Epub 2014 Dec 12.
[h=1]In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1.[/h] Tambunan US[SUP]1[/SUP], Rachmania RA[SUP]1[/SUP], Parikesit AA[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] This research focused on the modification of the functional groups of oseltamivir as neuraminidase inhibitor against influenza A virus subtype H1N1. Interactions of three of the best ligands were evaluated in the hydrated state using molecular dynamics simulation at two different temperatures. The docking result showed that AD3BF2D ligand (N-[(1S,6R)-5-amino-5-{[(2R,3S,4S)-3,4-dihydroxy-4-(hydroxymethyl) tetrahydrofuran-2-yl]oxy}-4-formylcyclohex-3-en-1-yl]acetamide-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate) had better binding energy values than standard oseltamivir. AD3BF2D had several interactions, including hydrogen bonds, with the residues in the catalytic site of neuraminidase as identified by molecular dynamics simulation. The results showed that AD3BF2D ligand can be used as a good candidate for neuraminidase inhibitor to cope with influenza A virus subtype H1N1.
[h=4]KEYWORDS:[/h] influenza; influenza A virus subtype (H1N1); molecular docking; molecular dynamics simulation; oseltamivir
PMID: 25859271 [PubMed] PMCID: PMC4389116 Free PMC Article
[h=1]In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1.[/h] Tambunan US[SUP]1[/SUP], Rachmania RA[SUP]1[/SUP], Parikesit AA[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] This research focused on the modification of the functional groups of oseltamivir as neuraminidase inhibitor against influenza A virus subtype H1N1. Interactions of three of the best ligands were evaluated in the hydrated state using molecular dynamics simulation at two different temperatures. The docking result showed that AD3BF2D ligand (N-[(1S,6R)-5-amino-5-{[(2R,3S,4S)-3,4-dihydroxy-4-(hydroxymethyl) tetrahydrofuran-2-yl]oxy}-4-formylcyclohex-3-en-1-yl]acetamide-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate) had better binding energy values than standard oseltamivir. AD3BF2D had several interactions, including hydrogen bonds, with the residues in the catalytic site of neuraminidase as identified by molecular dynamics simulation. The results showed that AD3BF2D ligand can be used as a good candidate for neuraminidase inhibitor to cope with influenza A virus subtype H1N1.
[h=4]KEYWORDS:[/h] influenza; influenza A virus subtype (H1N1); molecular docking; molecular dynamics simulation; oseltamivir
PMID: 25859271 [PubMed] PMCID: PMC4389116 Free PMC Article